SCHEMBL9258401

SCHEMBL9258401

CC(C)(C)c1ccccc1-c1cc(Cl)ccc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.42
S100A4 P26447 1/20 0.40
HSD11B1 P28845 2/20 0.39
HTR2B P41595 1/20 0.37
PDE4D Q08499 1/20 0.37
TP53 P04637 1/20 0.37
PDK2 Q15119 1/20 0.37
CNR2 P34972 2/20 0.36
TSHR P16473 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
ALDH1A1 P00352 1/20 0.36
TRPA1 O75762 1/20 0.36
ABCB1 P08183 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
CYP3A4 P08684 1/20 0.35
MAPK1 P28482 1/20 0.35
GPR3 P46089 1/20 0.35
PTPN11 Q06124 1/20 0.35
IDO1 P14902 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12618386 0.85 CYP3A4 (0.44) PTPN1S100A4HSD11B1PDE4DPDK2
SCHEMBL9258380 0.85 HSD11B1 (0.49) S100A4HSD11B1TP53PDK2TSHR
SCHEMBL9257716 0.84 HSD11B1 (0.43) S100A4HSD11B1PDK2TSHRTDP1
SCHEMBL9261398 0.82 CYP2A6 (0.44) HSD11B1TP53TSHRTDP1ALDH1A1
SCHEMBL9261586 0.80 ALDH1A1 (0.43) TSHRTDP1ALDH1A1MAPK1KDM4E
SCHEMBL9254220 0.80 HSP90AA1 (0.42) HTR2BPDK2ABCB1GPR3
SCHEMBL9261492 0.80 LMNA (0.38) HSD11B1TP53PDK2TSHRTDP1
SCHEMBL381603 0.78 PTPN1 (0.56) PTPN1S100A4HTR2BPDE4DTP53
SCHEMBL29416774 0.78 PTPN1 (0.56) PTPN1S100A4HTR2BPDE4DTP53
SCHEMBL29983105 0.78 PTPN1 (0.56) PTPN1S100A4HTR2BPDE4DTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND SHIONOGI & CO., LTD. (JP) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND BACE1, STS, APP PTPN1 2073/4885S100A4 732/4885HSD11B1 702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.